Showing results (201-210 of 271) with videos related to

Sort By:
Pageof 28
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort StudyBenjamin D Powers, James McDonald, Rahul Mhaskar, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resectionRyan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancerHop S Tran Cao, Alpana Balachandran, Huamin Wang, et al.
Annals of Surgical Oncology|December 19, 2014
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic CancerAmanda B Cooper, Rebecca Slack, David Fogelman, et al.
Journal of Proteome Research|May 24, 2019
Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic CancerPrasanta Dutta, Mayrim R Perez, Jaehyuk Lee, et al.
Pageof 28